Asimov creates tools for programming living cells. Its multidisciplinary team is advancing the design and manufacture of biologics and gene therapies by integrating mammalian synthetic biology, computer-aided design, and machine learning. Asimov was established in 2017 by Raja Srinivas in Boston, Massachusetts.